Broadcom
AVGO
Micron Technology
MU
Salesforce
CRM
4
Qualcomm
QCOM
5
Oracle
ORCL
US Stock MarketDetailed Quotes
CORT Corcept Therapeutics
- 71.790
- +2.520+3.64%
Close Apr 24 16:00 ET
- 71.790
- 0.0000.00%
Post 17:05 ET
7.57BMarket Cap58.37P/E (TTM)
76.170High69.110Low2.62MVolume69.220Open69.270Pre Close192.02MTurnover3.01%Turnover Ratio58.37P/E (Static)105.50MShares117.33052wk High11.15P/B6.24BFloat Cap22.60052wk Low--Dividend TTM86.95MShs Float117.330Historical High--Div YieldTTM10.19%Amplitude0.680Historical Low73.423Avg Price1Lot Size
Corcept Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 39.94%675.04M | 34.33%181.89M | 47.69%182.55M | 39.15%163.8M | 38.95%146.81M | 20.04%482.38M | 31.39%135.41M | 21.50%123.6M | 13.86%117.72M | 12.77%105.65M |
| Operating revenue | 39.94%675.04M | 34.33%181.89M | 47.69%182.55M | 39.15%163.8M | 38.95%146.81M | 20.04%482.38M | 31.39%135.41M | 21.50%123.6M | 13.86%117.72M | 12.77%105.65M |
| Cost of revenue | 67.91%10.88M | 57.49%2.96M | 74.29%2.87M | 60.36%2.52M | 82.90%2.54M | 20.35%6.48M | 26.82%1.88M | 22.85%1.65M | 19.60%1.57M | 10.88%1.39M |
| Gross profit | 39.56%664.16M | 34.00%178.93M | 47.33%179.68M | 38.86%161.27M | 38.37%144.27M | 20.03%475.89M | 31.46%133.53M | 21.48%121.96M | 13.79%116.14M | 12.80%104.27M |
| Operating expense | 43.02%527.21M | 50.87%153.67M | 46.60%133.08M | 45.20%125.68M | 28.36%114.77M | 29.87%368.61M | 28.81%101.86M | 32.61%90.78M | 22.54%86.56M | 36.16%89.42M |
| Selling and administrative expenses | 52.13%280.32M | 76.82%83.37M | 62.93%73.75M | 54.65%66.94M | 15.86%56.27M | 20.55%184.26M | 11.41%47.15M | 28.72%45.26M | 14.46%43.28M | 29.34%48.56M |
| Research and development costs | 33.92%246.89M | 28.50%70.3M | 30.36%59.34M | 35.74%58.75M | 43.22%58.51M | 40.74%184.35M | 48.85%54.71M | 36.72%45.52M | 31.84%43.28M | 45.27%40.85M |
| Operating profit | 27.66%136.95M | -20.23%25.26M | 49.46%46.6M | 20.31%35.59M | 98.61%29.5M | -4.75%107.28M | 40.76%31.67M | -2.37%31.18M | -5.88%29.58M | -44.51%14.85M |
| Net non-operating interest income expense | 42.07%24.54M | 30.31%6.7M | 21.83%6.35M | 79.38%6M | 53.39%5.49M | 385.66%17.28M | 189.25%5.14M | 386.73%5.21M | 431.27%3.35M | 4,376.25%3.58M |
| Non-operating interest income | 42.07%24.54M | 30.31%6.7M | 21.83%6.35M | 79.38%6M | 53.39%5.49M | 385.66%17.28M | 189.25%5.14M | 386.73%5.21M | 431.27%3.35M | 4,376.25%3.58M |
| Other net income (expense) | ||||||||||
| Special income (charges) | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Income before tax | 29.65%161.49M | -13.17%31.96M | 45.51%52.94M | 26.32%41.6M | 89.83%34.99M | 7.20%124.56M | 51.63%36.81M | 10.24%36.39M | 2.71%32.93M | -31.34%18.43M |
| Income tax | 10.14%20.28M | -77.74%1.21M | 14.44%5.73M | 13.07%6.11M | 183.01%7.23M | 24.67%18.42M | -28.94%5.45M | 412.16%5.01M | 16.17%5.4M | -36.94%2.56M |
| Net income | 33.04%141.21M | -1.94%30.75M | 50.47%47.21M | 28.92%35.49M | 74.83%27.76M | 4.66%106.14M | 88.87%31.36M | -9.33%31.38M | 0.42%27.53M | -30.35%15.88M |
| Net income continuous Operations | 33.04%141.21M | -1.94%30.75M | 50.47%47.21M | 28.92%35.49M | 74.83%27.76M | 4.66%106.14M | 88.87%31.36M | -9.33%31.38M | 0.42%27.53M | -30.35%15.88M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 33.04%141.21M | -1.94%30.75M | 50.47%47.21M | 28.92%35.49M | 74.83%27.76M | 4.66%106.14M | 88.87%31.36M | -9.33%31.38M | 0.42%27.53M | -30.35%15.88M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | 129.19%1.48M | 68.40%357K | 153.88%523K | 395.38%644K | 212K | 206K | ||||
| Net income attributable to common stockholders | 32.45%139.73M | -2.42%30.39M | 49.78%46.69M | 28.38%35.12M | 74.06%27.51M | 4.15%105.5M | 88.37%31.14M | -9.78%31.17M | -0.15%27.36M | -30.66%15.81M |
| Basic earnings per share | 32.35%1.35 | -3.33%0.29 | 45.16%0.45 | 25.93%0.34 | 80.00%0.27 | 7.37%1.02 | 100.00%0.3 | -3.13%0.31 | 3.85%0.27 | -31.82%0.15 |
| Diluted earnings per share | 30.85%1.23 | -7.14%0.26 | 46.43%0.41 | 28.00%0.32 | 78.57%0.25 | 8.05%0.94 | 100.00%0.28 | -6.67%0.28 | 4.17%0.25 | -30.00%0.14 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025